Reviews in Endocrine & Metabolic Disorders

Papers
(The median citation count of Reviews in Endocrine & Metabolic Disorders is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review184
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality156
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus144
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review110
Traumatic brain injury and prolactin98
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb85
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?78
Diagnostic and prognostic utility of phase angle in patients with cancer74
The genetics of Graves’ disease65
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review55
Endocrine responses of the stress system to different types of exercise55
Posttranslational modifications in diabetes: Mechanisms and functions54
Prolactin deficiency in the context of other pituitary hormone abnormalities48
Preface44
Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients43
Androgens, aging, and prostate health41
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond41
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic41
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease40
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease40
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence39
No longer to be ignored: Hypophosphatemia following intravenous iron administration39
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis36
Mention to Prof. Andrew V. Schally36
Hypothalamic GHRH36
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review35
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries35
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy34
Appetitive interoception, the hippocampus and western-style diet34
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome33
Correction: Hypothalamic GHRH33
Deep neural network for food image classification and nutrient identification: A systematic review33
Towards precision medicine in non-alcoholic fatty liver disease32
Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes32
Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing’s syndrome: A systematic review and meta-analysis30
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities30
The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations30
Novel treatments for congenital adrenal hyperplasia29
Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis29
Computational approaches to predicting treatment response to obesity using neuroimaging28
Uterine fibroids in women diagnosed with acromegaly: a systematic review28
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review28
Regulation of adipogenesis by exosomal milk miRNA27
Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection26
Rathke’s cleft cyst: From history to molecular genetics26
Vitamin D, infections and immunity26
Food cue reactivity: Neurobiological and behavioral underpinnings26
Correction to: Chemotherapy in NEN: still has a role?26
GHRH in diabetes and metabolism25
Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences25
Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects25
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients25
The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies24
Hypoprolactinemia, a neglected endocrine disorder24
Molecular testing for thyroid nodules: Where are we now?24
ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity24
Prolactin: structure, receptors, and functions24
The emerging role of transcription factor FOXP3 in thyroid cancer23
Gut-brain mechanisms underlying changes in disordered eating behaviour after bariatric surgery: a review23
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity23
Endogenous Cushing’s syndrome during pregnancy22
Phase angle in applications of bioimpedance in health and disease22
Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment – A Review22
Phase angle as an index of physiological status: validating bioelectrical assessments of hydration and cell mass in health and disease22
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities21
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications21
Phase angle and COVID-19: A systematic review with meta-analysis21
Phase angle in localized bioimpedance measurements to assess and monitor muscle injury21
A systematic review of resting-state functional connectivity in obesity: Refining current neurobiological frameworks and methodological considerations moving forward20
Contribution of the microbiome for better phenotyping of people living with obesity20
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group20
Reference intervals for serum prolactin concentrations: analytical and clinical considerations20
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions20
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management20
Surgical outcomes of partial adrenalectomy for pheochromocytoma: A systematic review and meta-analysis19
Efficacy of radiofrequency and laser thermal ablation in solving thyroid nodule-related symptoms and cosmetic concerns. A systematic review and meta-analysis19
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes19
Inborn errors of metabolism: Lessons from iPSC models19
Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management18
Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?18
Relevance of body composition in phenotyping the obesities18
Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis17
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies17
Association of maternal blood metabolomics and gestational diabetes mellitus risk: a systematic review and meta-analysis17
Hypoprolactinemia. Does it matter? Redefining the hypopituitarism and return from a mumpsimus17
Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing17
Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review17
Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?15
The role of bioelectrical phase angle in patients with heart failure15
Correction to: The role of transforming growth factor beta in thyroid autoimmunity: current knowledge and future perspectives15
Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?15
Current practice in intermediate risk differentiated thyroid cancer – a review15
Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions15
Incomplete penetrance and variable expressivity in monogenic diabetes; a challenge but also an opportunity15
New insights in thyroid diagnosis and treatment14
Extracellular vesicles—incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications14
Pasireotide—a novel somatostatin receptor ligand after 20 years of use14
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy14
Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-1914
Adrenal insufficiency in pregnancy: Physiology, diagnosis, management and areas for future research14
Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy14
Neuropsychological complications of hypoprolactinemia14
The endocrine adipose organ14
A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease13
The effect of bariatric surgery on the expression of gastrointestinal taste receptors: A systematic review13
Complexity in the interpretation and application of multiple guidelines for thyroid nodules: the need for coordinated recommendations for “small” lesions13
Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?13
Neurobiological regulation of eating behavior: Evidence based on non-invasive brain stimulation13
Ser/Thr phosphatases: One of the key regulators of insulin signaling13
Aging and androgens: Physiology and clinical implications13
Isolated hypoprolactinemia: The rarest of the rare?13
Growth hormone – releasing hormone in the immune system13
Progress, challenges and perspectives in the management of hypopituitarism12
Phase angle, muscle tissue, and resistance training12
Primary hyperparathyroidism: from guidelines to outpatient clinic12
Subclinical central hypothyroidism in patients with hypothalamic-pituitary disease: does it exist?12
Phase angle in assessment and monitoring treatment of individuals with respiratory disease12
The multifaceted progenitor fates in healthy or unhealthy adipose tissue during obesity11
Interactions between emotions and eating behaviors: Main issues, neuroimaging contributions, and innovative preventive or corrective strategies11
Growth hormone-releasing hormone signaling and manifestations within the cardiovascular system11
Childhood obesity, metabolic syndrome, and oxidative stress: microRNAs go on stage11
Pituitary adenomas: biology, nomenclature and clinical classification11
Clinical aspects of SARS-CoV-2 infection and vitamin D10
Melatonin administration on bone properties of animals under hypoestrogenism: A systematic review10
The use of phase angle in patients with digestive and liver diseases10
Cognition and psychological wellbeing in hypopituitary patients10
COVID-19 and hypopituitarism10
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism10
Dynamic risk assessment in patients with differentiated thyroid cancer10
The role of testosterone, the androgen receptor, and hypothalamic-pituitary–gonadal axis in depression in ageing Men10
The science of bioelectrical impedance-derived phase angle: insights from body composition in youth10
Endocrinological and inflammatory markers in individuals with spinal cord injury: A systematic review and meta-analysis9
Meal replacement therapy for obesity and diabetes remission: efficacy assessment and considerations of barriers and facilitators to adherence among U.S. individuals with low economic resources9
Thyroid cancer and insulin resistance9
The changing landscape of acromegaly – an epidemiological perspective9
Testosterone treatment of late-onset hypogonadism – benefits and risks9
Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care9
Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved9
The role of tissue oxygenation in obesity-related cardiometabolic complications9
The molecular basis of hypoprolactinaemia8
The relationship between low prolactin and type 2 diabetes8
Iron homeostasis and insulin sensitivity: unraveling the complex interactions8
Role of HOXA10 in pathologies of the endometrium8
Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot8
GHRH and its analogues in central nervous system diseases8
Vitamin D deficiency and cardiometabolic risk factors in adolescents: systematic review and meta-analysis8
Mechanisms linking obesity and its metabolic comorbidities with cerebral grey and white matter changes8
The relationship between thyroid and human-associated microbiota: A systematic review of reviews8
Cardiometabolic effects of hypoprolactinemia8
Meal replacements on obesity and leptin: a systematic review and meta-analysis8
The medicalization of testosterone: reinventing the elixir of life8
Dissecting ultra-processed foods and drinks: Do they have a potential to impact the brain?8
A novel approach for the treatment of AML, through GHRH antagonism: MIA-6028
Update on regulation of GHRH and its actions on GH secretion in health and disease8
Metabolic phenotyping in people living with obesity: Implications for dietary prevention8
0.19116306304932